Delivery Order SPE2DB22D1055-SPE2DB24FSGH9
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cyclophosphamide 500 mg/2.5 ml vials. The $1,557.60 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of November 29, 2024. The contract was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,071.08 firm fixed-price contract is for the delivery of Cyclophosphamide 1 GM/5 ML VL 5ML, a medical product, with a performance period through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $1,068.20 firm-fixed-price contract is for the supply of Cyclophosphamide 1 GM vials, with a completion date of September 4, 2024. The contract is not set aside. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,341.10 firm fixed-price contract is for the delivery of 2 gram vials of the medication cyclophosphamide, with a performance period ending on January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the supply of 4,568,324,077 units of the pharmaceutical drug Cyclophosphamide 2 GM Vials. The $30,981.56 firm fixed-price contract has a completion date of May 22, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,732,286 units of Cyclophosphamide 2 GM vials, a chemotherapy drug. The $70,284.14 firm-fixed-price contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,735.47 firm fixed price delivery order is for the supply of 4,568,451,278 units of the medication Cyclophosphamide 1 GM Vials, with an ultimate completion date of June 5, 2025. The contract is not set aside and represents an order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclophosphamide 2 GM/10 ML VL 10ML, a medical product, with a ceiling value of $3,139.38 and a period of performance through May 7, 2025. The contract is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclophosphamide 2 GM/10 ML VL 10ML, a medication used in the treatment of various medical conditions. The contract has a ceiling value of $3,886.98 and a period of performance through April 18, 2025. This award is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,553.88, is for the delivery of 4,568,075,876 units of the drug Cyclophosphamide 500 mg vials. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime...